United States  

Trusted News Discovery Since 2008		One News Page

Remdesivir

Antiviral drug

Remdesivir    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Remdesivir: Antiviral drug
Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. As of 2020, remdesivir is being tested as a specific treatment for COVID-19, and has been authorized for emergency use in the US, India, Singapore, and approved for use in Japan for people with severe symptoms. It also received approval in the UK in May 2020, however, it was going to be rationed due to limited supply. It may shorten the time it takes to recover from the infection.

0
shares		ShareTweetSavePostSend
 

Remdesivir becomes first COVID-19 drug put forward for use in the EU [Video]

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Remdesivir becomes first COVID-19 drug put forward for use in the EU

Credit: Euronews English     Duration: 00:34Published
FDA Warns Against Combining Remdesivir And Hydroxychloroquine [Video]

FDA Warns Against Combining Remdesivir And Hydroxychloroquine

The FDA has issued a warning to healthcare providers regarding two medications being tested with COVID-19. The warning cautions against administering hydroxychloroquine in combination with remdesivir...

Credit: Wochit News     Duration: 00:31Published
Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission' [Video]

Coronavirus cases in India reach 2.86 lakh, ICMR says no 'community transmission'

Coronavirus cases in India have crossed over 2.8 lakh. The country witnessed the highest single-day spike of 9,996 more cases in last 24 hours. In a single day, as many as 357 deaths were reported..

Credit: ANI     Duration: 01:51Published
Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment [Video]

Matt Hancock: New drug trial probably biggest step forward in Covid-19 treatment

Health Secretary Matt Hancock announced plans for a new trial of drug Remdesivir, a treatment originally developed to fight Ebola, which appears to shorten recovery time for people with Covid-19.

Credit: PA - Press Association STUDIO     Duration: 00:43Published

You Might Like


Remdesivir, the First Coronavirus Drug, Gets a Price Tag

Federal health officials and Gilead Sciences have settled on priority distribution to Americans — and nonnegotiable pricing.
NYTimes.com - Published

Fact check: China doesn't own patent for coronavirus treatment remdesivir

A viral claim that China owns remdesivir's patent through an agreement with a multi-national public health organization called Unitaid is false.
USATODAY.com - Published

Haphazard Rollout of Coronavirus Drug Frustrates Doctors

Remdesivir was shipped to small hospitals even as besieged medical centers were denied access.
NYTimes.com - Published

How Remdesivir, New Hope for Covid-19 Patients, Was Resurrected

The drug failed as a treatment for hepatitis and Ebola. With federal funding, scientists trained it on the coronavirus.
NYTimes.com - Published

FDA authorizes Remdesivir drug for COVID-19

President Donald Trump said on Friday the U.S. Food and Drug Administration (FDA) had granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug Remdesivir to..
Reuters - Published

Your Thursday Briefing

Coronavirus, Remdesivir, Unemployment: Here’s what you need to know.
NYTimes.com - Published

Gilead Claims ‘Positive Data’ to Come From N.I.H. Trial of Remdesivir

Neither the company nor the institutes discussed the data. Previous results for the potential coronavirus treatment have been inconclusive.
NYTimes.com - Published

What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirus

Remdesivir, a Gilead Sciences antiviral drug, is reportedly showing promise for the treatment of the coronavirus in clinical trials.
USATODAY.com - Published